J. Goldman & Co’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $464K | Buy |
67,500
+47,250
| +233% | +$325K | 0.01% | 276 |
|
|
2025
Q1 | $58.3K | Hold |
20,250
| – | – | ﹤0.01% | 300 |
|
|
2024
Q4 | $95.2K | Hold |
20,250
| – | – | ﹤0.01% | 303 |
|
|
2024
Q3 | $72.3K | Buy |
+20,250
| New | +$72.3K | ﹤0.01% | 310 |
|
|
2023
Q1 | – | Sell |
-59,100
| Closed | -$430K | – | 292 |
|
|
2022
Q4 | $430K | Sell |
59,100
-89,400
| -60% | -$651K | 0.02% | 207 |
|
|
2022
Q3 | $1.2M | Buy |
+148,500
| New | +$1.2M | 0.06% | 167 |
|